<!DOCTYPE html>
<html>
    <head>
        <meta charset="utf-8" />
        <meta name="viewport" content="width=device-width, height=device-height, initial-scale=1.0, maximum-scale=1.0, minimum-scale=1.0, user-scalable=no" />
        <title>Full STD Tx Guidelines</title>
        <link href="../jquery-mobile/jquery.mobile.theme-1.3.1.min.css" rel="stylesheet" type="text/css"/>
        <link href="../jquery-mobile/jquery.mobile.swatch.f.css" rel="stylesheet" type="text/css"/>
        <link href="../jquery-mobile/jquery.mobile.swatch.j.css" rel="stylesheet" type="text/css"/>
        <link href="../assets/css/custom_arrow.css" rel="stylesheet" type="text/css"/>
        <link href="../jquery-mobile/jquery.mobile.structure-1.3.1.min.css" rel="stylesheet" type="text/css"/>
        <link href="../assets/css/full.css" rel="stylesheet" type="text/css"/>
        <link href="../assets/css/recreated_tables.css" rel="stylesheet" type="text/css"/>
        <script src="../jquery-mobile/jquery-1.9.1.min.js" type="text/javascript"></script>
        <script src="../../jquery-customization.js" type="text/javascript"></script>
        <script src="../jquery-mobile/jquery.mobile-1.3.1.min.js" type="text/javascript"></script>
        <script src="../../cordova-2.7.0.js" type="text/javascript" charset="utf-8"></script>
        <script src="../assets/js/metrics.js" type="text/javascript" charset="utf-8"></script>
    </head>
    <body onload="onLoad()">
        <!-- Start of page -->
        <div data-role="page" id="g414" data-theme="d">
            <div data-role="header" data-id="guidelines-header" data-theme="j" data-position="fixed">
                <a href="lv-409.html" data-role="button" data-iconshadow="false" data-corners="false" data-theme="reset" data-transition="fade" class="back_button" role="button" aria-label="back"></a>
                <h1>Full STD Tx Guidelines</h1>
	            <a href="../menu.html"  rel="external" data-role="button" data-theme="reset" data-transition="fade" data-iconshadow="false" data-corners="false" class="menu_button ui-btn-right" role="button" aria-label="main menu"></a>
            </div>
            <div data-role="content">
            <div id=guidelines_breadcrumbs>
            
                    <a href="lv-0.html" >Full Guidelines</a><span class="carrot"> > </span>
                    <a href="lv-409.html" >References</a><span class="carrot"> > </span>References 201-250
            </div>
            </br><h2 id="sigil_toc_id_414">
 References 201-250
</h2>
<p>
 201. CDC. Syphilis testing algorithms using treponemal tests for initial screening&ndash;four laboratories, New York City, 2005&ndash;2006. MMWR 2008;57:872&ndash;5.
</p>
<p>
 202. Pope V. Use of treponemal tests to screen for syphilis. Infect Med 2004;21:399&ndash;402.
</p>
<p>
 203. Lukehart SA, Hook EW, III, Baker-Zander SA, et al. Invasion of the central nervous system by Treponema pallidum: implications for diagnosis&nbsp;and treatment. Ann Intern Med 1988;109:855&ndash;62.
</p>
<p>
 204. Marra CM, Maxwell CL, Smith SL, et al. Cerebrospinal fluid abnormalities&nbsp;in patients with syphilis: association with clinical and laboratory features. J Infect Dis 2004;189:369&ndash;76.
</p>
<p>
 205. Jaffe HW, Larsen SA, Peters M, et al. Tests for treponemal antibody in CSF. Arch Intern Med 1978;138:252&ndash;5.
</p>
<p>
 206. CDC. Inadvertent use of Bicillin&reg; C-R to treat syphilis infection &mdash; Los Angeles, California, 1999&ndash;2004. MMWR 2005;54:217&ndash;9.
</p>
<p>
 207. Ghanem KG, Erbelding EJ, Wiener ZS, et al. Serological response to syphilis treatment in HIV-positive and HIV-negative patients attending sexually transmitted diseases clinics. Sex Transm Infect 2007;83:97&ndash;101.
</p>
<p>
 208. Rolfs RT, Joesoef MR, Hendershot EF, et al; The Syphilis and HIV Study Group. A randomized trial of enhanced therapy for early syphilis in patients with and without human immunodeficiency virus infection. N Engl J Med 1997;337:307&ndash;14.
</p>
<p>
 209. Ghanem KG, Erbelding EJ, Cheng WW, et al. Doxycycline compared with benzathine penicillin for the treatment of early syphilis. Clin Infect Dis 2006;42:e45&ndash;9.
</p>
<p>
 210. Wong T, Singh AE, De P. Primary syphilis: serological treatment response to doxycycline/tetracycline versus benzathine penicillin. Am J Med 2008;121:903&ndash;8.
</p>
<p>
 211. Hook EW, III, Roddy RE, Handsfield HH. Ceftriaxone therapy for incubating and early syphilis. J Infect Dis 1988;158:881&ndash;4.
</p>
<p>
 212. Riedner G, Rusizoka M, Todd J, et al. Single-dose azithromycin versus penicillin G benzathine for the treatment of early syphilis. N Engl J Med 2005;353:1236&ndash;44.
</p>
<p>
 213. Hook EW, III, Martin DH, Stephens J, et al. A randomized, comparative&nbsp;pilot study of azithromycin versus benzathine penicillin G for treatment of early syphilis. Sex Transm Dis 2002;29:486&ndash;90.
</p>
<p>
 214. Hook EW, III, Behets F, Van DK, et al. A phase III equivalence trial of azithromycin versus benzathine penicillin for treatment of early syphilis. J Infect Dis 2010;201:1729&ndash;35.
</p>
<p>
 215. Lukehart SA, Godornes C, Molini BJ, et al. Macrolide resistance in Treponema pallidum in the United States and Ireland. N Engl J Med 2004;351:154&ndash;8.
</p>
<p>
 216. Mitchell SJ, Engelman J, Kent CK, et al. Azithromycin-resistant syphilis infection: San Francisco, California, 2000&ndash;2004. Clin Infect Dis 2006;42:337&ndash;45.
</p>
<p>
 217. Su JR, Hook E, Kenney K, et al. Prevalence of the 23S rRNA point mutation in Treponema pallidum in the United States and Associated Factors, 2006&ndash;2008. 18th International Society for Sexually Transmitted Diseases Research, #OS1.11.03. London, England: June 2009.
</p>
<p>
 218. Marra CM, Boutin P, McArthur JC, et al. A pilot study evaluating ceftriaxone and penicillin G as treatment agents for neurosyphilis in human immunodeficiency virus-infected individuals. Clin Infect Dis 2000;30:540&ndash;4.
</p>
<p>
 219. Marra CM, Maxwell CL, Tantalo L, et al. Normalization of cerebrospinal&nbsp;fluid abnormalities after neurosyphilis therapy: does HIV status matter? Clin Infect Dis 2004;38:1001&ndash;6.
</p>
<p>
 220. Marra CM, Maxwell CL, Tantalo LC, et al. Normalization of serum rapid plasma reagin titer predicts normalization of cerebrospinal fluid and clinical abnormalities after treatment of neurosyphilis. Clin Infect Dis 2008;47:893&ndash;9.
</p>
<p>
 221. Hook EW, III, Baker-Zander SA, Moskovitz BL, et al. Ceftriaxone therapy for asymptomatic neurosyphilis. Case report and Western blot analysis of serum and cerebrospinal fluid IgG response to therapy. Sex Transm Dis 1986;13(3 Suppl):S185&ndash;8.
</p>
<p>
 222. Shann S, Wilson J. Treatment of neurosyphilis with ceftriaxone. Sex Transm Infect 2003;79:415&ndash;6.
</p>
<p>
 223. Kingston AA, Vujevich J, Shapiro M, et al. Seronegative secondary syphilis in 2 patients coinfected with human immunodeficiency virus. Arch Dermatol 2005;141:431&ndash;3.
</p>
<p>
 224. CDC. Symptomatic early neurosyphilis among HIV-positive men who have sex with men: four cities, United States, January 2002&ndash;June 2004. MMWR 2007;56:625&ndash;8.
</p>
<p>
 225. Libois A, De WS, Poll B, et al. HIV and syphilis: when to perform a lumbar puncture. Sex Transm Dis 2007;34:141&ndash;4.
</p>
<p>
 226. Ghanem KG. Sensitivity and specificity of lumbar puncture in HIV-infected patients with syphilis and no neurologic symptoms reply. Clin Infect Dis 2009;49:162&ndash;3.
</p>
<p>
 227. Ghanem KG, Moore RD, Rompalo AM, et al. Neurosyphilis in a clinical cohort of HIV-1-infected patients. AIDS 2008;22:1145&ndash;51.
</p>
<p>
 228. Ghanem KG, Moore RD, Rompalo AM, et al. Antiretroviral therapy is associated with reduced serologic failure rates for syphilis among
</p>
<p>
 229. Dowell ME, Ross PG, Musher DM, et al. Response of latent syphilis or neurosyphilis to ceftriaxone therapy in persons infected with human immunodeficiency virus. Am J Med 1992;93:481&ndash;8.
</p>
<p>
 230. Smith NH, Musher DM, Huang DB, et al. Response of HIV-infected patients with asymptomatic syphilis to intensive intramuscular therapy with ceftriaxone or procaine penicillin. Int J STD AIDS 2004;15:328&ndash;32.
</p>
<p>
 231. Hollier LM, Harstad TW, Sanchez PJ, et al. Fetal syphilis: clinical and laboratory characteristics. Obstet Gynecol 2001;97:947&ndash;53.
</p>
<p>
 232. World Health Organization. The global elimination of congenital syphilis: rationale and strategy for action. Geneva: WHO Department of Reproductive Health and Research; 2005.
</p>
<p>
 233. Alexander JM, Sheffield JS, Sanchez PJ, et al. Efficacy of treatment for syphilis in pregnancy. Obstet Gynecol 1999;93:5&ndash;8.
</p>
<p>
 234. Walker GJ. Antibiotics for syphilis diagnosed during pregnancy. Cochrane Database Syst Rev 2001;CD001143.
</p>
<p>
 235. Wendel GD, Jr., Sheffield JS, Hollier LM, et al. Treatment of syphilis in pregnancy and prevention of congenital syphilis. Clin Infect Dis 2002;35(Suppl 2):S200&ndash;9.
</p>
<p>
 236. Klein VR, Cox SM, Mitchell MD, et al. The Jarisch-Herxheimer reaction complicating syphilotherapy in pregnancy. Obstet Gynecol 1990;75(3 Pt 1):375&ndash;80.
</p>
<p>
 237. Katz KA, Klausner JD. Azithromycin resistance in Treponema pallidum. Curr Opin Infect Dis 2008;21:83&ndash;91.
</p>
<p>
 238. Saxon A, Beall GN, Rohr AS, et al. Immediate hypersensitivity reactions to beta-lactam antibiotics. Ann Intern Med 1987;107:204&ndash;15.
</p>
<p>
 239. Yates AB. Management of patients with a history of allergy to beta-lactam antibiotics. Am J Med 2008;121:572&ndash;6.
</p>
<p>
 240. Manhart LE, Holmes KK, Hughes JP, et al. Mycoplasma genitalium among young adults in the United States: an emerging sexually transmitted&nbsp;infection. Am J Public Health 2007;97:1118&ndash;25.
</p>
<p>
 241. Ross JD, Jensen JS. Mycoplasma genitalium as a sexually transmitted infection: implications for screening, testing, and treatment. Sex Transm Infect 2006;82:269&ndash;71.
</p>
<p>
 242. Taylor-Robinson D, Gilroy CB, Thomas BJ, et al. Mycoplasma genitalium in chronic non-gonococcal urethritis. Int J STD AIDS 2004;15:21&ndash;5.
</p>
<p>
 243. Dupin N, Bijaoui G, Schwarzinger M, et al. Detection and quantification&nbsp;of Mycoplasma genitalium in male patients with urethritis. Clin Infect Dis 2003;37:602&ndash;5.&nbsp;
</p>
<p>
 244. Bradshaw CS, Tabrizi SN, Read TR, et al. Etiologies of nongonococcal&nbsp;urethritis: bacteria, viruses, and the association with orogenital exposure. J Infect Dis 2006;193:336&ndash;45.
</p>
<p>
 245. Madeb R, Nativ O, Benilevi D, et al. Need for diagnostic screening of herpes simplex virus in patients with nongonococcal urethritis. Clin Infect Dis 2000;30:982&ndash;3.
</p>
<p>
 246. Martin DH. Nongonococcal urethritis: new views through the prism of modern molecular microbiology. Curr Infect Dis Rep 2008;10:128&ndash;32.
</p>
<p>
 247. Schwebke JR, Hook EW, III. High rates of Trichomonas vaginalis among men attending a sexually transmitted diseases clinic: implications for screening and urethritis management. J Infect Dis 2003;188:465&ndash;8.
</p>
<p>
 248. Geisler WM, Yu S, Hook EW, III. Chlamydial and gonococcal infection&nbsp;in men without polymorphonuclear leukocytes on gram stain: implications for diagnostic approach and management. Sex Transm Dis 2005;32:630&ndash;4.
</p>
<p>
 249. Falk L, Fredlund H, Jensen JS. Tetracycline treatment does not eradicate Mycoplasma genitalium. Sex Transm Infect 2003;79:318&ndash;9.
</p>
<p>
 250. Mena LA, Mroczkowski TF, Nsuami M, et al. A randomized comparison of azithromycin and doxycycline for the treatment of Mycoplasma genitalium-positive urethritis in men. Clin Infect Dis 2009;48:1649&ndash;54.
</p>

            </div>
            <script type="text/javascript">
                $('#g414').on('pageshow', function (event, ui) {
                    document.addEventListener("deviceready", function(){
                        trackFullGuidelinesPageView('414');
                                                },true);
                });
            </script>
        </div>
        <!-- end of guidelines heading page -->
    </body>
</html>

